Keyword: Monoclonal antibodies
Markets & Companies
04.04.2016
- Analysts love looking into the future, particularly when it comes to big pharma’s prospect for growth and earnings. The industry experts of Morningstar see slowing patent losses...
Strategy & Management
07.10.2015
- The ability to rapidly deploy manufacturing capacity will be a strategic asset of the pharmaceutical industry in the future. NNE Pharmaplan has developed the “Bio on demand”...
News
21.09.2015
- US biopharmaceutical group Amgen is to acquire Dezima Pharma, a privately held Dutch biotechnology company focused on developing treatments for dyslipidemia. The transaction is...
News
16.01.2015
- Under a deal just signed, German drugmaker Boehringer Ingelheim will offer its production capabilities for monoclonal antibodies to French pharmaceutical producer Sanofi to support...
Plant Construction & Process Technology
11.09.2013
- Quality First - As the trend of specialized medicine continues to grow, so does the development of highly potent active pharmaceutical ingredients, better known as HPAPIs. Handling...
News
23.10.2012
- Lonza and OncoMed Pharmaceuticals, a clinical-stage biopharmaceutical company dedicated to improving cancer treatment, announced today an agreement for the development and...
Plant Construction & Process Technology
30.05.2011
- Doubled-Edged Sword - The emergence of biosimilars has caused very large ripples in the biopharma pond, and has recently been called the most "disruptive technology" of the decade...
Plant Construction & Process Technology
11.05.2011
- It was a most unusual road trip - Drivers on the highways of Europe were probably surprised to see the scaled-down equivalent of a bioprocessing production line rolling next to...
